James Concannon - IVH independent trustee

IVH Etf  USD 11.18  0.00  0.00%   
James Concannon is Portfolio Manager at IVH
Age 72
Tenure 7 years
Phone215-255-1200
Webhttps://www.ivyfunds.com/products-performance/mutual-funds/ivy-closed-end-funds/high-income-opportunities/991

Similar Fund Executives

Showing other executives

One Year Return

Robert HubbardBlackrock Debt Strategies
63
Thomas JasperBlackstone Gso Long
72
Margaret GrahamPioneer Floating Rate
72
George GormanEaton Vance Senior
69
K MannardNorthern Trust
N/A
Richard EricksonFirst Trust Senior
69
James KirchnerEaton Vance Senior
57
Michael CastellanoBlackRock Municipal Income
75
Thomas SouthNorthern Trust
52
Edward DAlelioBlackstone Gso Long
68
Scott WhistenAllianzgi Convertible Income
49
Gary SullivanPioneer Floating Rate
61
Kelly ODonnellPioneer Floating Rate
48
Frank FabozziBlackrock Debt Strategies
73
Thomas HarterAllianzgi Convertible Income
45
Marisa BeeneyBlackstone Gso Long
50
Jim WardNorthern Trust
N/A
Orhan DzemailiAllianzgi Convertible Income
46
James JacobsonAllianzgi Convertible Income
75
William HunterNuveen Global High
73
Cynthia FrostEaton Vance Senior
60
Ivy Funds - Delaware Ivy High Income Opportunities Fund is a closed ended fixed income mutual fund launched and managed by Ivy Investment Management Company. Ivy High is listed under Asset Management in the United States and is traded on New York Stock Exchange exchange. IVH [IVH] is traded in USA and was established null.

IVH Money Managers

Daniel Geatens, Senior Vice President Treasurer
Richard Salus, Chief Financial Officer, Senior Vice President
Philip Shipp, Assistant Secretary
James Gressett, Independent Trustee
Christianna Wood, Independent Trustee
James Concannon, independent trustee
Jerome Abernathy, Independent Trustee
Joseph Kauten, Principal Financial Officer, Principal Accounting Officer, Vice President Treasurer
Michael Smith, Independent Trustee
John Fry, Independent Trustee
Sandra Lawrence, Independent Trustee
H Dobbs, Independent Trustee
Scott Schneider, Chief Compliance Officer, Vice President
Thomas Whitford, Independent Trustee
David Connor, Senior Vice President General Counsel, Secretary
Edward Tighe, Independent Trustee
Ann Borowiec, Independent Trustee
Joseph Chow, Independent Trustee
Frank Ross, independent trustee
Shawn Lytle, President, Chief Executive Officer, Trustee
Jennifer Dulski, Secretary
Frances SevillaSacasa, Independent Trustee
Janet Yeomans, Independent Trustee
Glendon Johnson, Independent Trustee
Joseph Harroz, Independent Chairman of the Board of Trustees
Thomas Bennett, Independent Chairman of Board of Trustees
Henry Herrmann, President Trustee
Philip Sanders, President, Trustee

IVH Etf Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is IVH a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether IVH offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IVH's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ivh Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ivh Etf:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
The market value of IVH is measured differently than its book value, which is the value of IVH that is recorded on the company's balance sheet. Investors also form their own opinion of IVH's value that differs from its market value or its book value, called intrinsic value, which is IVH's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IVH's market value can be influenced by many factors that don't directly affect IVH's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IVH's value and its price as these two are different measures arrived at by different means. Investors typically determine if IVH is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IVH's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.